Mickaël J C Hiligsmann (Mickaël Hiligsmann, M Hiligsmann, Mickael Hiligsmann)

ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 115

Top Venues

Expert review of pharmacoeconomics & outcomes research

Journal of medical economics

PharmacoEconomics

The patient

This page only lists publications with an associated author ORCID identifier.

Publications

Mickaël J C Hiligsmann, Olivier Bruyère
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example. Global & regional health technology assessment 11 (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Mickaël J C Hiligsmann, Barry Liden, Charlotte Beaudart, Evi Germeni, Alissa Hanna, Maya Joshi, Catherine P Koola, Barry Stein, Mandy Tonkinson, Deborah Marshall, Simon Fifer
HTA community perspectives on the use of patient preference information: lessons learned from a survey with members of HTA bodies. International journal of technology assessment in health care 40 (1) (2024)
Lieke Maas, Annelies Boonen, Caroline E Wyers, Sandrine Bours, Joop P W van den Bergh, Silvia M A A Evers, Justin G L M Luermans, Mickaël J C Hiligsmann
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatments. Archives of osteoporosis 19 (1) (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Mickaël J C Hiligsmann, Barry Liden, Charlotte Beaudart, Evi Germeni, Alissa Hanna, Maya Joshi, Catherine P Koola, Barry Stein, Mandy Tonkinson, Deborah Marshall, Simon Fifer
HTA community perspectives on the use of patient preference information: lessons learned from a survey with members of HTA bodies. International journal of technology assessment in health care 40 (1) (2024)
Lieke Maas, Annelies Boonen, Nannan Li, Caroline E Wyers, Joop P W van den Bergh, Mickaël J C Hiligsmann
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services. Expert review of pharmacoeconomics & outcomes research (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Lieke Maas, Annelies Boonen, Nannan Li, Caroline E Wyers, Joop P W van den Bergh, Mickaël J C Hiligsmann
Cost-effectiveness of a multicomponent-adherence intervention in fracture liaison services. Expert review of pharmacoeconomics & outcomes research (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science (2024)
Mickaël J C Hiligsmann, Olivier Bruyère
The role and impact of health economics in the optimization of patient care in osteoarthritis: insights from a practical example. Global & regional health technology assessment 11 (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient (2024)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Mickaël J C Hiligsmann
Treatment Preference Research in Atopic Dermatitis: A Systematic Review of Quantitative Studies. The patient 17 (5) (2024)
Lieke Maas, Annelies Boonen, Caroline E Wyers, Sandrine Bours, Joop P W van den Bergh, Silvia M A A Evers, Justin G L M Luermans, Mickaël J C Hiligsmann
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatments. Archives of osteoporosis 19 (1) (2024)
Eva-Lotta Hinzpeter, Lakshmi Nagendra, Nadja Kairies-Schwarz, Charlotte Beaudart, Mickaël J C Hiligsmann
Stated Preferences of At-Risk Populations for the Treatment of Osteoporosis: A Systematic Review. The patient (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Mickaël J C Hiligsmann, Stuart L Silverman, Andrea J Singer, Leny Pearman, Yamei Wang, John Caminis, Jean-Yves Reginster
Comparison of the cost-effectiveness of sequential treatment with abaloparatide in US men and women at very high risk of fractures. Aging clinical and experimental research 36 (1) (2024)
Lieke Maas, Annelies Boonen, Caroline E Wyers, Sandrine Bours, Joop P W van den Bergh, Silvia M A A Evers, Justin G L M Luermans, Mickaël J C Hiligsmann
Societal costs before and up to 1 year after the first fracture liaison service visit in patients requiring anti-osteoporosis treatments. Archives of osteoporosis 19 (1) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Lieke Maas, Angelika Joos, Mickaël J C Hiligsmann
Pediatric Market Access: A Qualitative Study. Therapeutic innovation & regulatory science 58 (2) (2024)
Mickaël J C Hiligsmann, Barry Liden, Charlotte Beaudart, Evi Germeni, Alissa Hanna, Maya Joshi, Catherine P Koola, Barry Stein, Mandy Tonkinson, Deborah Marshall, Simon Fifer
HTA Community Perspectives on the Use of Patient Preference Information: Lessons Learned from a Survey with Members of HTA Bodies. International journal of technology assessment in health care (2024)
Mickaël J C Hiligsmann, Stuart S Silverman, Andrea J Singer, Leny Pearman, Jake Mathew, Yamei Wang, John Caminis, Jean-Yves Reginster
Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. PharmacoEconomics (2023)
Jalal Dahham, Mickaël J C Hiligsmann, Ingrid E H Kremer, Samia Joseph Khoury, Hala Darwish, Hassan Hosseini, Silvia M A A Evers, Rana G Rizk
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert review of pharmacoeconomics & outcomes research 23 (4) (2023)
Anna Tichler, Dorijn F L Hertroijs, Dirk Ruwaard, Martijn C G J Brouwers, Mickaël J C Hiligsmann, Judith D De Jong, Arianne Mathilda Josephus Elissen
Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes. Patient preference and adherence 17 (2023)
Jalal Dahham, Mickaël J C Hiligsmann, Ingrid E H Kremer, Samia Joseph Khoury, Hala Darwish, Hassan Hosseini, Silvia M A A Evers, Rana G Rizk
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert review of pharmacoeconomics & outcomes research (2023)
Ingrid E H Kremer, Charlotte Beaudart, Joost Simons, Hiskya Plieger, Melanie Schroeder, Mickaël J C Hiligsmann
Preferences of people living with HIV for injectable and oral antiretroviral treatment in the Netherlands: a discrete choice experiment. AIDS care (2023)
Mickaël J C Hiligsmann, Stuart S Silverman, Andrea J Singer, Leny Pearman, Jake Mathew, Yamei Wang, John Caminis, Jean-Yves Reginster
Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. PharmacoEconomics (2023)
Valérie N E Schuermans, Ruud Droeghaag, Sem M M Hermans, Anouk Y J M Smeets, Inge J M H Caelers, Mickaël J C Hiligsmann, Wouter L W van Hemert, Silvia Evers, Henk van Santbrink, null null
Advocating uniformity in spine surgery: a practical disease-specific guideline for trial-based economic evaluations. BMJ open 13 (7) (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics 41 (4) (2023)
Mickaël J C Hiligsmann, Stuart S Silverman, Andrea J Singer, Leny Pearman, Jake Mathew, Yamei Wang, John Caminis, Jean-Yves Reginster
Cost-Effectiveness of Sequential Abaloparatide/Alendronate in Men at High Risk of Fractures in the United States. PharmacoEconomics (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics 41 (4) (2023)
Damon Willems, C J Sayed, H H Van der Zee, J R Ingram, E Hinzpeter, C Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
A discrete-choice experiment to elicit the treatment preferences of patients with hidradenitis suppurativa in the United States. Journal of medical economics (2023)
Jalal Dahham, Mickaël J C Hiligsmann, Ingrid E H Kremer, Samia Joseph Khoury, Hala Darwish, Hassan Hosseini, Silvia M A A Evers, Rana G Rizk
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert review of pharmacoeconomics & outcomes research (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics 41 (4) (2023)
Sophie Böger, Ilja van Bergen, Charlotte Beaudart, Kei-Long Cheung, Mickaël J C Hiligsmann
Preference of young adults for COVID-19 vaccination in the United Kingdom - a discrete choice experiment. Expert review of pharmacoeconomics & outcomes research (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics 41 (4) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics 41 (4) (2023)
Jalal Dahham, Mickaël J C Hiligsmann, Ingrid E H Kremer, Samia Joseph Khoury, Hala Darwish, Hassan Hosseini, Silvia M A A Evers, Rana G Rizk
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert review of pharmacoeconomics & outcomes research (2023)
Jalal Dahham, Mickaël J C Hiligsmann, Ingrid E H Kremer, Samia Joseph Khoury, Hala Darwish, Hassan Hosseini, Silvia M A A Evers, Rana G Rizk
The societal costs of multiple sclerosis in Lebanon: a cross-sectional study. Expert review of pharmacoeconomics & outcomes research 23 (4) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient (2023)
Rebecca Jane Moon, Jean-Yves Reginster, Nasser M Al-Daghri, Jotheeswaran A Thiyagarajan, Charlotte Beaudart, Olivier Bruyère, Nansa Burlet, Manju Chandran, Mario Coelho da Silva, Philip Gerard Conaghan, Willard H Dere, Adolfo Diez-Perez, Peyman Hadji, Philippe Halbout, Mickaël J C Hiligsmann, John A Kanis, Eugene V McCloskey, Sif Ormarsdottir, Daniel Prieto-Alhambra, Régis Pierre Radermecker, René Rizzoli, Yousef Al Saleh, Stuart L Silverman, Lee S Simon, Friederike Thomasius, Tjeerd Pieter van Staa, Andrea Laslop, Cyrus Cooper, Nicholas C W Harvey
Real-world evidence: new opportunities for osteoporosis research. Recommendations from a Working Group from the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO). Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics (2023)
Katja C Heinz, Charlotte Beaudart, Damon Willems, Isabell Wiethoff, Mickaël J C Hiligsmann
Cost-Effectiveness of Emerging Treatments for Atopic Dermatitis: A Systematic Review. PharmacoEconomics (2023)
Anna Tichler, Dorijn F L Hertroijs, Dirk Ruwaard, Martijn C G J Brouwers, Mickaël J C Hiligsmann, Judith D De Jong, Arianne Mathilda Josephus Elissen
Preferred Conversation Topics with Respect to Treatment Decisions Among Individuals with Type 2 Diabetes. Patient preference and adherence 17 (2023)
Damon Willems, Eva-Lotta Hinzpeter, Hessel H Van der Zee, Christopher J Sayed, John R Ingram, Charlotte Beaudart, Silvia M A A Evers, Mickaël J C Hiligsmann
Patient Preferences in the Management of Hidradenitis Suppurativa: Results of a Multinational Discrete Choice Experiment in Europe. The patient 16 (2) (2023)
Lieke Maas, Nele Raskin, Marloes van Onna, Dennis Cornelissen, Sandrine Bours, Trudy van der Weijden, Joop P W van den Bergh, Marsha M van Oostwaard, Caroline E Wyers, Mickaël J C Hiligsmann, Annelies Boonen
Development and usability of a decision aid to initiate anti-osteoporosis medication treatment in patients visiting the fracture liaison service with a recent fracture. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA (2023)
Nannan Li, Charlotte Beaudart, Jane A Cauley, Steven W Ing, Nancy E Lane, Jean-Yves Reginster, Stuart Silverman, Andrea J Singer, Mickaël J C Hiligsmann
Correction to: Cost Effectiveness Analyses of Interventions for Osteoporosis in Men: A Systematic Literature Review. PharmacoEconomics (2023)
Ruud Droeghaag, Valérie N E Schuermans, Sem M M Hermans, Anouk Y J M Smeets, Inge J M H Caelers, Mickaël J C Hiligsmann, Silvia Evers, Wouter L W van Hemert, Henk van Santbrink
Methodology of economic evaluations in spine surgery: a systematic review and qualitative assessment. BMJ open 13 (3) (2023)
Nannan Li, Annelies Boonen, Joop P W van den Bergh, Justin G L M Luermans, Caroline E Wyers, Marsha M van Oostwaard, Lisanne Vranken, Sandrine P G Bours, Mickaël J C Hiligsmann
A head-to-head comparison of EQ-5D-5L and SF-6D in Dutch patients with fractures visiting a Fracture Liaison Service. Journal of medical economics 25 (1) (2022)
Plaxcedes Chiwire, Axel Christian Mühlbacher, Silvia M A A Evers, H Mahomed, Hy V Huynh, Mickaël J C Hiligsmann
A discrete choice experiment investigating HIV testing preferences in South Africa. Journal of medical economics 25 (1) (2022)
Loes Hilhorst, Jip van der Stappen, Joran Lokkerbol, Mickaël J C Hiligsmann, Anna H Risseeuw, Bea G Tiemens
Patients' and Psychologists' Preferences for Feedback Reports on Expected Mental Health Treatment Outcomes: A Discrete-Choice Experiment. Administration and policy in mental health 49 (5) (2022)
Elizabeth M Curtis, Jean-Yves Reginster, Nasser M Al-Daghri, Emmanuel Biver, Maria Luisa Brandi, Cavalier Etienne, Peyman Hadji, Philippe Halbout, Nicholas C W Harvey, Mickaël J C Hiligsmann, Muhammad Kassim Javaid, John A Kanis, Jean-Marc Kaufman, Olivier Lamy, Radmila Matijevic, Adolfo Diez Perez, Régis Pierre Radermecker, Mário Miguel Rosa, Thierry Thomas, Friederike Thomasius, Mila Vlaskovska, René Rizzoli, Cyrus Cooper
Management of patients at very high risk of osteoporotic fractures through sequential treatments. Aging clinical and experimental research 34 (4) (2022)
Boudewijn Dc Heggen, Chava L Ramspek, Koen E A van der Bogt, Michiel W de Haan, Marc H Hemmelder, Mickaël J C Hiligsmann, Magda M van Loon, Joris I Rotmans, Jan H M Tordoir, Friedo W Dekker, Geert Willem H Schurink, Maarten G J Snoeijs, null null
Optimising Access Surgery in Senior Haemodialysis Patients (OASIS): study protocol for a multicentre randomised controlled trial. BMJ open 12 (2) (2022)
Paul Mark Mitchell, Rachael Lisa Morton, Mickaël J C Hiligsmann, Samantha Husbands, Joanna Coast
Estimating loss in capability wellbeing in the first year of the COVID-19 pandemic: a cross-sectional study of the general adult population in the UK, Australia and the Netherlands. The European journal of health economics : HEPAC : health economics in prevention and care (2022)
Jalal Dahham, Ingrid E H Kremer, Mickaël J C Hiligsmann, Kamal Hamdan, Abdallah Nassereddine, Silvia M A A Evers, Rana G Rizk
Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon. Applied health economics and health policy (2022)
Katja C Heinz, Damon Willems, Mickaël J C Hiligsmann
Economic evaluation of a JAK inhibitor compared to a monoclonal antibody for treatment of moderate-to-severe atopic dermatitis from a UK perspective. Journal of medical economics 25 (1) (2022)
Mihajlo Michael Jakovljevic, Chia Jie Tan, Nathorn Chaiyakunapruk, Guilherme Silva Julian, Kei-Long Cheung, Mickaël J C Hiligsmann, Brian B Godman, Sylvia Opanga, Paul A Scuffham, Michael Gregg
Global article collection: essential reads from around the world. Journal of medical economics 25 (1) (2022)
Bjoern Schwander, Klaus Kaier, Mickaël J C Hiligsmann, Silvia M A A Evers, Mark Nuijten
Does the Structure Matter? An External Validation and Health Economic Results Comparison of Event Simulation Approaches in Severe Obesity. PharmacoEconomics 40 (9) (2022)
Jalal Dahham, Rana G Rizk, Ingrid E H Kremer, Silvia M A A Evers, Mickaël J C Hiligsmann
Economic Burden of Multiple Sclerosis in Low- and Middle-Income Countries: A Systematic Review. PharmacoEconomics 39 (7) (2021)
Wiesława Dominika Wranik, Ronaldo-Raul Székely, Susanne Mayer, Mickaël J C Hiligsmann, Kei-Long Cheung
The most important facilitators and barriers to the use of Health Technology Assessment in Canada: a best-worst scaling approach. Journal of medical economics 24 (1) (2021)
Tamara Dangouloff, Camille Botty, Charlotte Beaudart, Laurent Servais, Mickaël J C Hiligsmann
Systematic literature review of the economic burden of spinal muscular atrophy and economic evaluations of treatments. Orphanet journal of rare diseases 16 (1) (2021)
Hoi Yau Chan, Ben F M Wijnen, Mickaël J C Hiligsmann, Filip Smit, Loes A M Leenen, Marian H J M Majoie, Silvia M A A Evers
Assessment of Quality of Life 8-Dimension (AQoL-8D): translation, validation, and application in two Dutch trials in patients with epilepsy and schizophrenia. Expert review of pharmacoeconomics & outcomes research (2021)
Mickaël J C Hiligsmann, S Maggi, N Veronese, L Sartori, J-Y Reginster
Cost-effectiveness of buffered soluble alendronate 70 mg effervescent tablet for the treatment of postmenopausal women with osteoporosis in Italy. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (3) (2021)
Jalal Dahham, Rana G Rizk, Mickaël J C Hiligsmann, Caroline Daccache, Samia Joseph Khoury, Hala Darwish, Silvia M A A Evers, Ingrid E H Kremer
The Economic and societal burden of multiple sclerosis on lebanese society: a cost-of-illness and quality of life study protocol. Expert review of pharmacoeconomics & outcomes research (2021)
Ruud Droeghaag, Valérie N E Schuermans, Sem M M Hermans, Anouk Y J M Smeets, Inge J M H Caelers, Mickaël J C Hiligsmann, Wouter L W van Hemert, Silvia Evers, Henk van Santbrink
Evidence-based recommendations for economic evaluations in spine surgery: study protocol for a Delphi consensus. BMJ open 11 (12) (2021)
Damon Willems, Mickaël J C Hiligsmann, Hessel H van der Zee, Christopher J Sayed, Silvia M A A Evers
Identifying Unmet Care Needs and Important Treatment Attributes in the Management of Hidradenitis Suppurativa: A Qualitative Interview Study. The patient (2021)
Bjoern Schwander, Mark Nuijten, Silvia M A A Evers, Mickaël J C Hiligsmann
Replication of Published Health Economic Obesity Models: Assessment of Facilitators, Hurdles and Reproduction Success. PharmacoEconomics 39 (4) (2021)
Sushmita Mohapatra, Kei-Long Cheung, Mickaël J C Hiligsmann, Nana Anokye
Most Important Factors for Deciding Rehabilitation Provision for Severe Stroke Survivors Post Hospital Discharge: A Study Protocol for a Best-Worst Scaling Experiment. Methods and protocols 4 (2) (2021)
Madhuri Pattamatta, Laura F C Fransen, Annemarie C P Dolmans-Zwartjes, Grard A P Nieuwenhuijzen, Silvia M A A Evers, Ewout A Kouwenhoven, Marc J van Det, Mickaël J C Hiligsmann, Misha D P Luyer
Effect of direct oral feeding following minimally invasive esophagectomy on costs and quality of life. Journal of medical economics 24 (1) (2021)
Hidde D Veldman, R T A L de Bot, I C Heyligers, T A E J Boymans, Mickaël J C Hiligsmann
Cost-effectiveness analyses comparing cemented, cementless, hybrid and reverse hybrid fixation in total hip arthroplasty: a systematic overview and critical appraisal of the current evidence. Expert review of pharmacoeconomics & outcomes research 21 (4) (2021)
Plaxcedes Chiwire, Silvia M A A Evers, H Mahomed, Mickaël J C Hiligsmann
Willingness to pay for primary health care at public facilities in the Western Cape Province, Cape Town, South Africa. Journal of medical economics 24 (1) (2021)
Hoi Yau Chan, Ben F M Wijnen, Marian H J M Majoie, Silvia M A A Evers, Mickaël J C Hiligsmann
Economic evaluation of deep brain stimulation compared with vagus nerve stimulation and usual care for patients with refractory epilepsy: A lifetime decision analytic model. Epilepsia 63 (3) (2021)
Luca M M Janssen, Mickaël J C Hiligsmann, Arianne Mathilda Josephus Elissen, Manuela A Joore, Nicolaas C Schaper, J H A Bosma, Coen D A Stehouwer, S J S Sep, Annemarie Koster, Miranda T Schram, Silvia M A A Evers
Burden of disease of type 2 diabetes mellitus: cost of illness and quality of life estimated using the Maastricht Study. Diabetic medicine : a journal of the British Diabetic Association 37 (10) (2020)
Damon Willems, Mata Charokopou, Silvia M A A Evers, Mickaël J C Hiligsmann
Early health economic modelling for a treatment candidate in hidradenitis suppurativa. Journal of medical economics 23 (12) (2020)
Noem Sain, Damon Willems, Mata Charokopou, Mickaël J C Hiligsmann
The importance of understanding patient and physician preferences for psoriasis treatment characteristics: a systematic review of discrete-choice experiments. Current medical research and opinion 36 (8) (2020)
Eric Sijstermans, Kei-Long Cheung, Anne J M Goossens, Rafael Conde, Javier-Leonardo Gonzalez-Rodriguez, Mickaël J C Hiligsmann
A discrete choice experiment to assess patients' preferences for HIV treatment in the urban population in Colombia. Journal of medical economics 23 (8) (2020)
Anne J M Goossens, Kei-Long Cheung, Eric Sijstermans, Rafael Conde, Javier-Leonardo Gonzalez-Rodriguez, Mickaël J C Hiligsmann
A discrete choice experiment to assess patients' preferences for HIV treatment in the rural population in Colombia. Journal of medical economics 23 (8) (2020)
Mickaël J C Hiligsmann, Kei-Long Cheung
Understanding patients' preferences for HIV treatment among rural and urban Colombian patients. Journal of medical economics 23 (8) (2020)
Maike Tünneßen, Mickaël J C Hiligsmann, Stephanie Stock, Vera Vennedey
Patients' preferences for the treatment of anxiety and depressive disorders: a systematic review of discrete choice experiments. Journal of medical economics 23 (6) (2020)
Nannan Li, Dennis Cornelissen, Stuart Silverman, Daniel Pinto, Lei Si, Ingrid Kremer, Sandrine Bours, Robin de Bot, Annelies Boonen, Silvia Evers, Joop van den Bergh, Jean-Yves Reginster, Mickaël J C Hiligsmann
An Updated Systematic Review of Cost-Effectiveness Analyses of Drugs for Osteoporosis. PharmacoEconomics 39 (2) (2020)
Irina Pokhilenko, Luca M M Janssen, Mickaël J C Hiligsmann, Silvia M A A Evers, Ruben M W A Drost, Aggie T G Paulus, Leonarda G M Bremmers
The Relative Importance of Education and Criminal Justice Costs and Benefits in Economic Evaluations: A Best-Worst Scaling Experiment. PharmacoEconomics 39 (1) (2020)
M Pattamatta, B J J Smeets, Silvia M A A Evers, E G Peters, Misha D P Luyer, Mickaël J C Hiligsmann
Quality of life and costs of patients prior to colorectal surgery. Expert review of pharmacoeconomics & outcomes research 20 (2) (2019)
Ben F M Wijnen, Frederick W Thielen, Steef Konings, Talitha Feenstra, Mark van der Gaag, Wim Veling, Lieuwe De Haan, Helga Ising, Mickaël J C Hiligsmann, Silvia M A A Evers, Filip Smit, Joran Lokkerbol
Designing and Testing of a Health-Economic Markov Model for Prevention and Treatment of Early Psychosis. Expert review of pharmacoeconomics & outcomes research 20 (3) (2019)
Sandra Diekmann, Laura Hörster, Silvia M A A Evers, Mickaël J C Hiligsmann, Götz Gelbrich, Klaus Gröschel, Rolf Wachter, Gerhard F Hamann, Pawel Kermer, Jan Liman, Mark Weber-Krüger, null null, Jürgen Wasem, Anja Neumann
Economic evaluation of prolonged and enhanced ECG Holter monitoring in acute ischemic stroke patients. Current medical research and opinion 35 (11) (2019)
Dorijn F L Hertroijs, Arianne Mathilda Josephus Elissen, M C G J Brouwers, Mickaël J C Hiligsmann, N C Schaper, D Ruwaard
Preferences of people with Type 2 diabetes for diabetes care: a discrete choice experiment. Diabetic medicine : a journal of the British Diabetic Association 37 (11) (2019)
Madhuri Pattamatta, Silvia M A A Evers, Boudewijn J J Smeets, Emmeline G Peters, Misha D P Luyer, Mickaël J C Hiligsmann
An economic evaluation of perioperative enteral nutrition in patients undergoing colorectal surgery (SANICS II study). Journal of medical economics 22 (3) (2018)

Mickaël J C Hiligsmann.css-eqlu8i{font-size:small;padding-left:4px;} (Mickaël Hiligsmann, M Hiligsmann, Mickael Hiligsmann)

Publication Activity (10 Years)

Top Topics

Top Venues

Mickaël J C Hiligsmann (Mickaël Hiligsmann, M Hiligsmann, Mickael Hiligsmann)